S. 839 (112th): Combating Designer Drugs Act of 2011
Apr 14, 2011
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on July 28, 2011, in a previous session of Congress, but was not enacted.
Senator from Minnesota
Read Text »
Last Updated: Jul 28, 2011
Length: 4 pages
About the bill
- Full Title
A bill to ban the sale of certain synthetic drugs.
- What is a bill?
The “S.” in “S. 839” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
5 cosponsors (3D, 2R) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 839 — 112th Congress: Combating Designer Drugs Act of 2011. Retrieved from https://www.govtrack.us/congress/bills/112/s839
“S. 839 — 112th Congress: Combating Designer Drugs Act of 2011.” www.GovTrack.us. 2011. May 22, 2015 <https://www.govtrack.us/congress/bills/112/s839>
|title=S. 839 (112th)
|accessdate=May 22, 2015
|author=112th Congress (2011)
|date=April 14, 2011
|quote=Combating Designer Drugs Act of 2011